Determination of calcium level in plasma, serum and urine is used for monitoring and as an aid in the diagnosis of clinical conditions associated with hypocalcemia and hypercalcemia. Increase in calcium concentration occurs in endocrine disorders such as primary hyperparathyroidism, hyperthyroidism, adrenal insufficiency and in malignant neoplasms. Low calcium level can occur in cirrhosis, nephrotic syndrome, hypoparathyroidism, hypothyroidism, in dialysis patients, and tetany. The test is  used to monitor the effectiveness of calcium supplementation in patients with osteoporosis.



arsenazo III, colorimetric


serum, plasma, urine

On board stability

up to 12 weeks

Calibration stability

up to 12 weeks

Measuring range

0,32-22 mg/dl

Regulatory status


Reagent lines

  • Multipurpose Line
    Liquick Cor-CALCIUM ARSENAZO 30
    Liquick Cor-CALCIUM ARSENAZO 60
    Liquick Cor-CALCIUM ARSENAZO 120

  • ACCENT-200

  • ACCENT-300

  • A-400

  • A-800

  • Prestige 24i
    Prestige 24i CALCIUM ARSENAZO (24 positions reagent tray)
    Prestige 24i CALCIUM ARSENAZO (36 positions reagent tray)

  • B50

  • OS

  • HC

Panels: bone metabolism, electrolytes, routine screening, oncological, pregnancy, renal

Available reagents

The specification was based on data determined on selected analyzers. We recommend that all users should refer to the instruction for use (IFU) and instruments’ user or service manuals before proceeding.

We Are Driven By Quality

Order this product

Order this product

To order this product, please contact your Area Sales Manager for details. If you have any questions, click the button below and fill out the form. We will contact you as soon as possible.


PZ Cormay S.A.

Ursynów Business Park
303 Pulawska Street
02-785 Warsaw, Poland